Literature DB >> 9362254

Ischemic preconditioning triggers phospholipase D signaling in rat heart.

A Tosaki1, N Maulik, G Cordis, O C Trifan, L M Popescu, D K Das.   

Abstract

Recent studies have indicated that repeated brief episodes of ischemia and reperfusion render the myocardium more tolerant to subsequent lethal ischemic injury. In view of the previous observations that ischemia-reperfusion potentiates phospholipase D signaling and that such signaling is beneficial for the heart, we investigated whether a similar phospholipase D signaling is responsible for the beneficial effects associated with repeated ischemia and reperfusion. Using an isolated perfused working rat heart model, we demonstrated that four brief episodes of 5 min of ischemia and 10 min of reperfusion reduced the incidence of ventricular arrhythmias, enhanced the postischemic ventricular performance, and decreased the release of creatine kinase from the reperfused heart, with simultaneous activation of phospholipase D generating the second messengers diacylglycerol and phosphatidic acid and leading to the translocation and activation of protein kinase C. The specific antiphospholipase D antibody blocked the activation of phospholipase D and attenuated the generation of diacylglycerol and phosphatidic acid and activation of protein kinase C. In concert, phospholipase D inhibition increased the incidence of ventricular arrhythmias, blocked the beneficial effects of preconditioning on the ventricular performance, and increased the amount of creatine kinase release from the coronary effluent. The results of this study indicate that repeated brief episodes of ischemia and reperfusion exert beneficial effects on the intact rat heart by triggering the activation of a phospholipase D signaling mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362254     DOI: 10.1152/ajpheart.1997.273.4.H1860

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

Review 1.  Mitochondrial therapeutics for cardioprotection.

Authors:  Raquel S Carreira; Pamela Lee; Roberta A Gottlieb
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 2.  Revisited and revised: is RhoA always a villain in cardiac pathophysiology?

Authors:  Shigeki Miyamoto; Dominic P Del Re; Sunny Y Xiang; Xia Zhao; Geir Florholmen; Joan Heller Brown
Journal:  J Cardiovasc Transl Res       Date:  2010-05-27       Impact factor: 4.132

3.  Cardioprotective effect of the Hibiscus rosa sinensis flowers in an oxidative stress model of myocardial ischemic reperfusion injury in rat.

Authors:  Karunakaran K Gauthaman; Mohamed T S Saleem; Peter T Thanislas; Vinoth V Prabhu; Karthikeyan K Krishnamoorthy; Niranjali S Devaraj; Jayaprakash S Somasundaram
Journal:  BMC Complement Altern Med       Date:  2006-09-20       Impact factor: 3.659

Review 4.  Lysophospholipid receptor activation of RhoA and lipid signaling pathways.

Authors:  Sunny Yang Xiang; Stephanie S Dusaban; Joan Heller Brown
Journal:  Biochim Biophys Acta       Date:  2012-09-15

5.  Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury.

Authors:  Sanjay Kumar Banerjee; Amit Kumar Dinda; Subhash Chandra Manchanda; Subir Kumar Maulik
Journal:  BMC Pharmacol       Date:  2002-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.